AC
Avoro Capital Advisors LLC
NEW YORK NY · SEC CIK 0001633313
$11.14B2026Q2 reported value
26Positions
79.5%Top 10 weight · largest 13.5%
1 / 8New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
CYTK Added+$141.98M
DFTX Added+$102.97M
UTHR Added+$80.07M
ARWR Added+$53.43M
FTH New+$36.10M
2026Q2 top sells estimated at quarter-end value
APELLIS PHARMACE Sold out-$491.70M
CENTESSA PHARMAC Sold out-$454.02M
TERNS PHARMACEUT Sold out-$300.24M
SOLENO THERAPEUT Sold out-$77.00M
ALKS Sold out-$42.43M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | $1.51B | 13.52% | 2,777,777 | 147,777 | 5.6% | $80.07M | Added |
| ASND | ASCENDIS PHARMA | $1.36B | 12.24% | 5,111,111 | 48,611 | 1.0% | $12.97M | Added |
| KRYS | KRYSTAL BIOTECH INC | $1.07B | 9.64% | 2,888,888 | 0 | 0.0% | — | Unchanged |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $984.41M | 8.84% | 1,833,333 | 15,152 | 0.8% | $8.14M | Added |
| ARGX | ARGENX SE | $927.77M | 8.33% | 1,000,000 | 0 | 0.0% | — | Unchanged |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $925.59M | 8.31% | 11,355,555 | 655,556 | 6.1% | $53.43M | Added |
| KYMR | KYMERA THERAPEUTICS INC | $857.13M | 7.70% | 7,474,747 | 0 | 0.0% | — | Unchanged |
| RVMD | REVOLUTION MEDICINES INC | $430.18M | 3.86% | 2,297,000 | -47,444 | -2.0% | -$8.89M | Reduced |
| CYTK | CYTOKINETICS INC | $425.95M | 3.82% | 4,999,999 | 1,666,666 | 50.0% | $141.98M | Added |
| CELC | CELCUITY INC | $355.71M | 3.19% | 3,400,000 | 25,000 | 0.7% | $2.62M | Added |
| GPCR | STRUCTURE THERAPEUTICS INC | $351.84M | 3.16% | 6,555,555 | 0 | 0.0% | — | Unchanged |
| XENE | XENON PHARMACEUTICALS INC | $348.75M | 3.13% | 5,777,777 | 0 | 0.0% | — | Unchanged |
| DFTX | DEFINIUM THERAPEUTICS INC | $338.17M | 3.04% | 7,188,888 | 2,188,888 | 43.8% | $102.97M | Added |
| QURE | UNIQURE NV | $309.88M | 2.78% | 6,727,777 | 768,182 | 12.9% | $35.38M | Added |
| VERA | VERA THERAPEUTICS INC | $245.61M | 2.21% | 5,723,888 | -165,000 | -2.8% | -$7.08M | Reduced |
| TSHA | TAYSHA GENE THERAPIES INC | $162.68M | 1.46% | 23,888,888 | 2,188,888 | 10.1% | $14.91M | Added |
| OCUL | OCULAR THERAPEUTIX INC | $123.14M | 1.11% | 12,540,000 | 225,000 | 1.8% | $2.21M | Added |
| DMRA | DAMORA THERAPEUTICS INC | $98.40M | 0.88% | 3,783,000 | 0 | 0.0% | — | Unchanged |
| COAG | HEMAB THERAPEUTICS HLDGS INC | $70.71M | 0.63% | 1,925,150 | 1,925,150 | — | — | First reported |
| GHRS | GH RESEARCH PLC | $48.38M | 0.43% | 1,800,000 | 0 | 0.0% | — | Unchanged |
| VRDN | VIRIDIAN THERAPEUTICS INC | $45.92M | 0.41% | 2,500,000 | 1,000,000 | 66.7% | $18.37M | Added |
| SEPN | SEPTERNA INC | $44.79M | 0.40% | 1,337,500 | 0 | 0.0% | — | Unchanged |
| AVTX | AVALO THERAPEUTICS | $43.12M | 0.39% | 2,333,333 | 923,333 | 65.5% | $17.06M | Added |
| FTH | FAETH THERAPEUTICS INC | $36.10M | 0.32% | 1,444,039 | 1,444,039 | — | $36.10M | New |
| WHWK | WHITEHAWK THERAPEUTICS INC | $13.05M | 0.12% | 2,849,402 | 0 | 0.0% | — | Unchanged |
| LXEO | LEXEO THERAPEUTICS INC | $6.93M | 0.06% | 1,489,189 | -385,811 | -20.6% | -$1.80M | Reduced |
| — | APELLIS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -12,222,222 | -100.0% | -$491.70M | Sold out |
| — | CENTESSA PHARMACEUTICALS PLC | $0 | 0.00% | 0 | -11,430,455 | -100.0% | -$454.02M | Sold out |
| — | TERNS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -5,695,000 | -100.0% | -$300.24M | Sold out |
| — | SOLENO THERAPEUTICS INC | $0 | 0.00% | 0 | -2,300,000 | -100.0% | -$77.00M | Sold out |
| ALKS | ALKERMES PLC | $0 | 0.00% | 0 | -1,200,000 | -100.0% | -$42.43M | Sold out |
| UTHR | UNITED THERAPEUTICS CORP Call | $0 | 0.00% | 0 | -380,000 | -100.0% | -$10.30M | Sold out |
| MNKD | MANNKIND CORP | $0 | 0.00% | 0 | -2,200,000 | -100.0% | -$5.39M | Sold out |
| CELC | CELCUITY INC Call | $0 | 0.00% | 0 | -200,000 | -100.0% | -$3.05M | Sold out |